Detalhe da pesquisa
1.
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Lancet
; 395(10233): 1345-1360, 2020 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171078
2.
Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872070
3.
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Lancet Child Adolesc Health
; 6(2): 86-95, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871570
4.
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
Lancet Infect Dis
; 19(9): 952-961, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345710
5.
A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam.
Am J Trop Med Hyg
; 94(4): 879-885, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856909